首页|First Affiliated Hospital of Nanjing Medical University Reports Findings in Lung Cancer (Advancing lung adenocarcinoma prognosis and immunotherapy prediction wi th a multi-omics consensus machine learning approach)
First Affiliated Hospital of Nanjing Medical University Reports Findings in Lung Cancer (Advancing lung adenocarcinoma prognosis and immunotherapy prediction wi th a multi-omics consensus machine learning approach)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Oncology - Lung Cancer is the subject of a report. According tonews reporting originating in Nanjing, People’s Republic of China, by NewsRx journalists, research stated,“Lung adeno carcinoma (LUAD) is a tumour characterized by high tumour heterogeneity. Althoug h thereare numerous prognostic and immunotherapeutic options available for LUAD , there is a dearth of precise,individualized treatment plans.”
NanjingPeople’s Republic of ChinaAsi aAdenocarcinomaCancerCyborgsDrugs and TherapiesEmerging TechnologiesHealth and MedicineImmunotherapyLung CancerLung Diseases and ConditionsM achine LearningOncology
NETL
NSTL
